Session » Vasculitis – ANCA-Associated Poster I: Epidemiology, Outcomes, and Classification
-
Abstract Number: 0432
Predictive Factors of Eosinophilic Granulomatosis with Polyangiitis Long-term Evolution: Data from a European Cohort
-
Abstract Number: 0433
Clustering of Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis – Using a Pre-processed Harmonised Dataset
-
Abstract Number: 0434
Sex Based Differences in Cardiovascular Conditions Associated with Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Analysis of the National Inpatient Sample
-
Abstract Number: 0435
Onset of ANCA-associated Vasculitides in Systemic Sclerosis: Phenotype, Management and Outcomes
-
Abstract Number: 0436
Clinical Characteristics and Outcome of ANCA-Associated Vasculitides Induced by Anti-Thyroid Drugs: A Multicenter Retrospective Cohort Study
-
Abstract Number: 0437
Outcome Measures in Patients with Neurologic Involvement in ANCA-associated Vasculitis: Data from Multicenter Longitudinal Observational Study
-
Abstract Number: 0438
Characterization of Interstitial Lung Disease in the Presence of Antineutrophil Cytoplasmic Antibodies
-
Abstract Number: 0439
Clinical Characteristics of Patients with ANCA-Associated Vasculitis with and Without Alpha-1 Antitrypsin Deficiency Alleles
-
Abstract Number: 0440
COVID-19 in Patients with ANCA Associated Vasculitis – Single Center Experience
-
Abstract Number: 0441
Patient-Reported Outcomes in ANCA-Associated Vasculitis: Interactions Between Patients’ and Physicians’ Perspectives in a Mexican Cohort
-
Abstract Number: 0442
Induction Therapy Patterns for Severe ANCA-associated Vasculitis Differ Based on Physician Specialty, Expertise, and Practice Setting: An International Survey
-
Abstract Number: 0443
Prognosis of Non-PR3 ANCA-Associated Vasculitis with Glomerulonephritis
-
Abstract Number: 0444
Prevalence of Frailty and Associated Factors in Patients with Vasculitis
-
Abstract Number: 0445
Cardiovascular Burden in Patients with ANCA-Associated and Non-ANCA Associated Vasculitis
-
Abstract Number: 0446
The Burden of Coronary Artery Calcification in ANCA-Associated Vasculitis
-
Abstract Number: 0447
Is Systemic Vasculitis a Risk Factor for Myocardial Infarction? A Retrospective Cohort Study from the National Inpatient Sample
-
Abstract Number: 0448
All-Cause and Cause-Specific Mortality in ANCA-Associated Vasculitis: A Population-based Study
-
Abstract Number: 0449
Higher Disease Acuity at Presentation and Increased Lower Respiratory Involvement in Hispanic and Black Patients with ANCA-Associated Vasculitis
-
Abstract Number: 0450
Incidence of Solid and Hematologic Tumors in Patients with ANCA: A 10-year Retrospective Cohort Study
-
Abstract Number: 0451
Incidence and Prevalence of ANCA-associated Vasculitis in Southern Sweden – a 23-year Study
-
Abstract Number: 0452
Evaluation of the 2022 ACR/EULAR Classification Criteria for ANCA-Associated Vasculitis in a Population-based Cohort from Sweden
-
Abstract Number: 0453
Validation of the 2022 – American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria in Patients with ANCA Associated Vasculitis
-
Abstract Number: 0454
Advantages and Disadvantages in Applying 2022 ACR/EULAR Classification Criteria to Conventionally Diagnosed Japanese GPA Patients
-
Abstract Number: 0455
Performance of 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria in Turkish Vasculitis Patients